OSHA Inspection: CUMBERLAND VALLEY RHEUMATOLOGY, P.C.

Issued

Oct 25, 2012

Abate by

Nov 16, 2012

Penalty

Initial $1,020 · Current $765 Reduced

General-duty citation text

29 CFR 1910.1030(c)(1)(i):  Each employer having an employee(s) with occupational exposure as defined by paragraph (b) of this section shall establish a written Exposure Control Plan designed to eliminate or minimize employee exposure.    (a) Cumberland Valley Rheumatology - The employer did not develop and implement a written exposure control plan for employees who are exposed to bloodborne pathogens, on or about September 5,2012.    ABATEMENT NOTE:    The exposure control plan shall contain at least the following elements:    1. The exposure determination required by paragraph (c)(2).    2. The schedule and method of implementation.    3. Methods of Compliance.    4. The procedure for the evaluation of circumstances surrounding exposure incidents as required by paragraph (f)(3)(i) of this standard.

Issued

Oct 25, 2012

Abate by

Nov 16, 2012

Penalty

Initial $0 · Current $0

General-duty citation text

29 CFR 1910.1030(f)(2)(iv): The employer did not ensure that employees who decline to accept hepatitis B vaccination offered by the employer sign the statement in Appendix A.    (a) Cumberland Valley Rheumatology - The employer did not ensure that employees who declined the hepatitis B vaccination signed a declination letter, on or about September 5, 2012.

Issued

Oct 25, 2012

Abate by

Nov 16, 2012

Penalty

Initial $0 · Current $0

General-duty citation text

29 CFR 1910.1030(g)(2)(i): The employer did not train each employee with occupational exposure in accordance with the requirements of this section. Such training must be provided at no cost to the employee and during working hours. The employer shall institute a training program and ensure employee participation in the program.    (a) Cumberland Valley Rheumatology - The employer did not provide training to employees who are exposed to bloodborne pathogens while performing infusions or phlebotomy, on or about September 5, 2012.  ABATEMENT NOTE:    The training program shall contain at a minimum the following elements:  1. An accessible copy of the regulatory text of this standard and an explanation of its contents.  2. A general explanation of the epidemiology and symptoms of bloodborne diseases.  3. An explanation of the modes of transmission of bloodborne pathogens.  4. An explanation of the employer's exposure control plan and the means by which the employees can obtain a copy of the written plan.  5. An explanation of the appropriate methods of recognizing tasks and other activities that may involve exposure in blood and other potentially infectious materials.  6. An explanation of the use and limitations of methods that will prevent or reduce exposure including appropriate engineering controls, work practices, and personal protective equipment.  7. Information on the types, proper use, location, removal, handling, decontamination, and disposal of personal pro- tective equipment.  8. An explanation of the basis for selection of personal protective equipment.  9. Information on the hepatitis B vaccine, including infor- mation on its efficiency, safety, method of administra- tion, the benefits of being vaccinated, and that the vaccine and vaccination will be offered free of charge.  10. Information on the appropriate actions to take and persons to contact in an emergency involving blood or other potentially infectious materials.  11. An explanation of the procedure to follow if an exposure incident occurs, including the method of reporting the incident and the medical follow-up that will be made available.  12. Information on the post-exposure and follow-up that the employer is required to provide for the employee following an exposure incident.  13. An explanation of the signs and labels and/or color coding required by (g)(1); and  14. An opportunity for interactive questions and answers with the person conducting the training session.